Secondary Intracranial Hypertension After Ciprofloxacin Treatment:A Case Report

Authors

  • Pena Acevedo L Integrated Laboratory of Specialized Medicine (LIME), Research Group in Pharmacology and Toxicology (INFARTO). Facultad de Medicina, IPS Universitaria, Universidad de Antioquia, Medellín, Colombia Author
  • Diaz Velez L Integrated Laboratory of Specialized Medicine (LIME), Research Group in Pharmacology and Toxicology (INFARTO). Facultad de Medicina, IPS Universitaria, Universidad de Antioquia, Medellín, Colombia Author
  • Rodriguez Pena S Grupo de Evidencia Terapéutica, Farmacología Clínica, Universidad de la Sabana, Bogotá, Colombia Author

DOI:

https://doi.org/10.47363/JCET/2021(2)122

Keywords:

ciprofloxacin, idiopathic intracranial hypertension, pseudo tumor cerebri, adverse drug reaction.

Abstract

A 30-year-old man developed secondary osteomyelitis after a traumatic amputation of his right index finger. The infection was treated with ciprofloxacin. Approximately 4 weeks after starting treatment, he complained of a progressive decrease in visual acuity, retro-ocular pain and bitemporal headache. A diagnosis of intracranial hypertension was established. Blood sample analysis, infectious profile, cerebrospinal fluid analysis, and neuroimaging were normal. Visual acuity and other symptoms progressively improved after stopping drug treatment. There were no complications or sequelae. Intracranial hypertension due to fluoroquinolones is described in the medical literature, its appearance during such treatments, despite being a rare adverse event, should be monitored.

Author Biographies

  • Pena Acevedo L, Integrated Laboratory of Specialized Medicine (LIME), Research Group in Pharmacology and Toxicology (INFARTO). Facultad de Medicina, IPS Universitaria, Universidad de Antioquia, Medellín, Colombia

    Integrated Laboratory of Specialized Medicine (LIME), Research Group in Pharmacology and Toxicology (INFARTO). Facultad de Medicina,
    IPS Universitaria, Universidad de Antioquia, Medellín, Colombia

  • Diaz Velez L, Integrated Laboratory of Specialized Medicine (LIME), Research Group in Pharmacology and Toxicology (INFARTO). Facultad de Medicina, IPS Universitaria, Universidad de Antioquia, Medellín, Colombia

    Integrated Laboratory of Specialized Medicine (LIME), Research Group in Pharmacology and Toxicology (INFARTO). Facultad de Medicina,
    IPS Universitaria, Universidad de Antioquia, Medellín, Colombia

  • Rodriguez Pena S, Grupo de Evidencia Terapéutica, Farmacología Clínica, Universidad de la Sabana, Bogotá, Colombia

    Grupo de Evidencia Terapéutica, Farmacología Clínica, Universidad de la Sabana, Bogotá, Colombia

Downloads

Published

2021-12-31

Issue

Vol. 2 No. 4 (2021): Volume 2 Issue 4

Section

Articles